首页> 外文期刊>Clinical and experimental dermatology >High levels of LIGHT and low levels of soluble herpesvirus entry mediator in sera of patients with atopic dermatitis
【24h】

High levels of LIGHT and low levels of soluble herpesvirus entry mediator in sera of patients with atopic dermatitis

机译:特应性皮炎患者血清中的高水平光照和低水平可溶性疱疹病毒进入介体

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives/Aims: To review seven children with Angelman syndrome (AS) undergoing 16 general anesthetics for both invasive and noninvasive procedures to determine if these children are at greater risk for anesthetic-related complications than the general population. Background: Children with AS may exhibit unpredictable responses to GABA agonists because of abnormal GABA receptors. These abnormal receptors may affect AS patients' responses to sedation and general anesthesia. Methods: The study design was a retrospective chart review of seven patients with AS who underwent a total of 16 general anesthetics for a variety of invasive and noninvasive procedures between the years 4/25/2005 and 12/31/2010. We reviewed the preoperative orders, anesthesia record and PACU records for preoperative medication orders and intraoperative and PACU adverse events. Results: We could not find documentation of complications attributed to the delivery of general anesthesia regardless of chromosomal defect, the use of GABA activating drugs, or a history of seizures. Six patients received a propofol-based anesthetic while 10 patients received potent inhalation agent for anesthetic maintenance. There were no statistical differences between the PACU lengths of stay (LOS) for AS patients as compared to the average PACU LOS for the 60 969 postprocedure patients cared for between 1/1/06 through 12/31/10. Conclusions: We found no data to suggest that these patients demonstrate exaggerated responses to GABA stimulating drugs. In fact, it appears that regardless of the anesthetic agent, the perioperative course was unremarkable.
机译:目的/目的:回顾7名接受16种全身麻醉剂的Angelman综合征(AS)儿童的有创和无创手术,以确定这些儿童是否比普通人群有更高的麻醉相关并发症风险。背景:患有AS的儿童可能会由于GABA受体异常而对GABA激动剂表现出无法预测的反应。这些异常的受体可能会影响AS患者对镇静和全身麻醉的反应。方法:本研究设计是回顾性图表,回顾了2005年4月25日至2010年12月31日期间接受了16种全身麻醉剂的7例AS患者的各种有创和无创手术。我们回顾了术前命令,麻醉记录和PACU记录,了解术前用药顺序以及术中和PACU不良事件。结果:无论染色体缺陷,使用GABA激活药物或有癫痫病史,我们都找不到归因于全身麻醉的并发症。 6例患者接受了以异丙酚为基础的麻醉剂,而10例患者接受了用于维持麻醉剂的强效吸入剂。与60 969名接受术后1/1/06至12/31/10的患者的平均PACU LOS相比,AS患者的PACU住院时间(LOS)之间没有统计学差异。结论:我们没有发现数据表明这些患者对GABA刺激药物表现出过大的反应。实际上,看来无论使用何种麻醉药,围手术期的效果都不显着。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号